ClinicalTrials.gg
CompletedNCT07916025Updated Nov 4, 2026

Effects of Mindfulness and Breathing Exercises in University Students

An interventional study of Guided Mindfullness Group and Breathing Exercise Group in Anxiety and Worry, Exam Anxiety and Self Esteem, sponsored by Alanya Alaaddin Keykubat University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-04.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Alanya Alaaddin Keykubat University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Apr 2026, registered Oct 2026).
Updated Nov 4, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
106
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This study compared the effects of guided mindfulness and breathing exercises on mindfulness, self-esteem, and anxiety in university students. Mindfulness means paying attention to present-moment experiences without judgment. The researchers expected both programs to improve mindfulness and self-esteem and reduce anxiety compared with continuing usual daily activities.

The study included three groups: a mindfulness group, a breathing exercise group, and a no-intervention control group. Students in the two intervention groups attended face-to-face group sessions lasting 20-25 minutes each day for five days. The control group continued usual daily activities without receiving a study intervention.

Questionnaires were completed before and immediately after the five-day study period. These assessed mindfulness, self-esteem, anxiety at the time of assessment, the general tendency to experience anxiety, and examination-related anxiety. Changes were compared across the three groups.

Read the detailed description

University students face academic demands that may contribute to anxiety, including anxiety associated with examinations. Brief mindfulness and breathing programs offer approaches that can be delivered within a short period. Comparing programs with the same session frequency and duration allows their relative effects to be examined under a similar time commitment.

The study compared each active program with a no-intervention control group and compared the two active programs with each other. The control group provided a reference for changes occurring over the same assessment period.

Both active programs included attention to breathing. Their comparison therefore concerned the complete programs as delivered, including their shared and distinct components. The study also examined the hypothesis that guided mindfulness would produce greater improvements in mindfulness and anxiety than breathing exercises.

02

Conditions studied

  • Anxiety and Worry
  • Exam Anxiety
  • Self Esteem
  • Breathing Exercise

Browse trials for

Keywords

  • Anxiety
  • Exam Anxiety
  • Self Esteem
  • breathing exercise
  • university students
03

In context

Anxiety Disorders Unverified

7,201 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.

This study's enrollment of 106 is above the median of 80 across 6,057 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Alanya Alaaddin Keykubat University is the lead sponsor of 51 studies on the registry; 17 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

IInclusion Criteria:

  • Aged 18-30years.
  • Enrolled as an undergraduate student at Alanya Alaaddin Keykubat University.
  • Able to read and write Turkish.
  • Willing to participate voluntarily and provide written .
  • No regular mindfulness or meditation training during the six months preceding enrollment.

Exclusion Criteria:

  • Current use of psychiatric medication.
  • Currently receiving psychiatric treatment.
  • Intermediate or advanced meditation practice.
  • History of neurological disease.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
106 participants (actual)

Study arms

  • Experimental
    Guided Mindfulness Group

    Participants received a guided mindfulness program consisting of face-to-face group sessions lasting 20-25 minutes daily for five consecutive days. Sessions focused on body awareness, breath awareness, and observing thoughts, emotions, and sensations in the present moment without judgment.

    Behavioral: Guided Mindfullness Group

  • Experimental
    Breathing Exercise Group

    Participants received a guided breathing exercise program consisting of face-to-face group sessions lasting 20-25 minutes daily for five consecutive days. The program included breath awareness, diaphragmatic breathing, slow controlled breathing with equal inhalation and exhalation durations, and breathing with a prolonged exhalation. The final session focused on applying the techniques to examination-related stress.

    Behavioral: Breathing Exercise Group

  • No intervention
    No-Intervention Control Group

    Participants continued their usual daily activities during the five-day study period. No study intervention was provided. Outcome questionnaires were completed at the same time points as in the intervention groups: before the study period and immediately after the five-day period.

Interventions

  • BehavioralGuided Mindfullness Group

    Participants received a guided mindfulness program consisting of face-to-face group sessions lasting 20-25 minutes daily for five consecutive days. Sessions focused on body awareness, breath awareness, and observing thoughts, emotions, and sensations in the present moment without judgment.

  • BehavioralBreathing Exercise Group

    Participants received a guided breathing exercise program consisting of face-to-face group sessions lasting 20-25 minutes daily for five consecutive days. The program included breath awareness, diaphragmatic breathing, slow controlled breathing with equal inhalation and exhalation durations, and breathing with a prolonged exhalation. The final session focused on applying the techniques to examination-related stress.

06

What researchers measure

Primary outcomes

  1. Change in Five Facet Mindfulness Questionnaire-Short Form (FFMQ-SF) Total Score

    Dispositional mindfulness was assessed using the Turkish version of the Five Facet Mindfulness Questionnaire-Short Form (FFMQ-SF). This self-report questionnaire contains 20 items rated on a five-point scale from 1 to 5. After appropriate reverse scoring, total scores range from 20 to 100, with higher scores indicating greater mindfulness. Change was calculated as the post-intervention total score minus the baseline total score. Positive change values indicate increased mindfulness, whereas negative values indicate decreased mindfulness.

    Time frame: Baseline (before the five-day study period) and Day 5 (immediately after completion of the five-day study period)

Secondary outcomes

  1. Change in State-Trait Anxiety Inventory State Anxiety Subscale (STAI-S) Total Score

    State anxiety was assessed using the state anxiety subscale of the Turkish State-Trait Anxiety Inventory (STAI-S). This 20-item self-report scale measures anxiety at the time of assessment. Items are rated on a four-point scale from 1 to 4. After appropriate reverse scoring, total scores range from 20 to 80, with higher scores indicating greater state anxiety. Change was calculated as the post-intervention total score minus the baseline total score. Negative change values indicate reduced anxiety.

    Time frame: Baseline (before the five-day study period) and Day 5 (immediately after completion of the five-day study period)

  2. Change in State-Trait Anxiety Inventory Trait Anxiety Subscale (STAI-T) Total Score

    Trait anxiety was assessed using the trait anxiety subscale of the Turkish State-Trait Anxiety Inventory (STAI-T). This 20-item self-report scale measures the general tendency to experience anxiety across situations. Items are rated on a four-point scale from 1 to 4. After appropriate reverse scoring, total scores range from 20 to 80, with higher scores indicating greater trait anxiety. Change was calculated as the post-intervention total score minus the baseline total score. Negative change values indicate reduced anxiety.

    Time frame: Baseline (before the five-day study period) and Day 5 (immediately after completion of the five-day study period)

  3. Change in Multidimensional Test Anxiety Scale (MTAS) Total Score

    Test anxiety was assessed using the Turkish version of the Multidimensional Test Anxiety Scale (MTAS). This 16-item self-report scale covers worry, cognitive interference, tension, and physiological indicators of test anxiety. Items are rated on a five-point scale from 1 to 5. Total scores range from 16 to 80, with higher scores indicating greater test anxiety. Change was calculated as the post-intervention total score minus the baseline total score. Negative change values indicate reduced test anxiety.

    Time frame: Baseline (before the five-day study period) and Day 5 (immediately after completion of the five-day study period)

  4. Change in Rosenberg Self-Esteem Scale (RSES) Total Score

    Self-esteem was assessed using the 10-item Rosenberg Self-Esteem Scale (RSES). Responses were scored from 0 to 3, with appropriate reverse scoring applied to obtain a summated total score ranging from 0 to 30. Higher scores indicate greater self-esteem. Change was calculated as the post-intervention total score minus the baseline total score. Positive change values indicate increased self-esteem, whereas negative values indicate decreased self-esteem.

    Time frame: Baseline (before the five-day study period) and Day 5 (immediately after completion of the five-day study period)

07

Study locations

1 site
  • Alanya Alaaddin Keykubat University
    Antalya, Alanya, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — De-identified individual participant data underlying the study results, together with the analysis code and data audit log, will be available from the corresponding author upon reasonable request. Sharing will be subject to the conditions of the ethics approval and participant consent, with appropriate measures to protect participant confidentiality.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2026 to primary completion in Apr 2026, 0 months.

Of 3,836 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 0 months is below that.

Counting every sponsor, half of 3,938 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 29, 2026
First posted
Nov 4, 2026
StartActual
Apr 6, 2026
Primary completionActual
Apr 15, 2026
CompletionActual
Apr 15, 2026
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07916025
Lead sponsor
Alanya Alaaddin Keykubat University
Responsible party
Ayça Araci (Assistant Professor, Alanya Alaaddin Keykubat University) — Principal investigator
First posted
Nov 4, 2026
Start date
Apr 6, 2026
Primary completion
Apr 15, 2026
Completion
Apr 15, 2026
Last update
Nov 4, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion